Natural Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Review

被引：4

作者：

Singh, Sonia ^{[1
]}

Sharma, Himanshu ^{[2
]}

Ramankutty, Raghavan ^{[3
]}

Ramaswamy, Sarada ^{[3
]}

Agrawal, Nitin ^{[4
]}

机构：

[1] GLA Univ, Inst Pharmaceut Res, Mathura 281406, Uttar Pradesh, India

[2] GLA Univ, Dept Comp Engn & Applicat, Mathura 281406, Uttar Pradesh, India

[3] Datha Ayuryoga Int Hlth Inst, DOO, Podgorica, Montenegro

[4] Raja Balwant Singh Engn Tech Campus, Fac Pharm, Agra 283105, Uttar Pradesh, India

来源：

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING | 2023年 / 26卷 / 15期

关键词：

PCSK9; LDL; cholesterol; inhibitors; monoclonal antibodies; ER; DENSITY-LIPOPROTEIN RECEPTOR; LUPIN PROTEIN; PCSK9; EXPRESSION; GREEN TEA; EPIGALLOCATECHIN GALLATE; INSULIN-RESISTANCE; GENE-EXPRESSION; BERBERINE; CHOLESTEROL; PHARMACOKINETICS;

D O I：

10.2174/1386207326666230627122630

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

PCSK9 (proprotein convertase subtilisin/kexin type 9) is an enzyme that helps to reduce cardiovascular events. This clinical result is attributable primarily to the crucial involvement of PCSK9 in regulating the low-density lipoprotein cholesterol level. Because oral anti-PCSK9 medications have yet to be available, the benefits of this unique treatment approach have been diminished. Identifying naturally occurring PCSK9 inhibitors may lead to considerable progress in this regard. These inhibitors serve as a starting point for producing oral and effective components that could be used with statins to boost the proportion of patients who achieve their LDL-cholesterol goals. In this review, we have briefly summarised the recent information regarding natural components or extracts that have been shown to inhibit PCSK9 activity.

引用

页码：2668 / 2678

页数：11

共 107 条

[81] Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions [J].

Santangelo, Rosaria ;

Silvestrini, Andrea ;

Mancuso, Cesare .

FOOD AND CHEMICAL TOXICOLOGY, 2019, 123 :42-49

[82] Pre-Clinical Pharmacokinetic and Pharmacodynamic Characterization of Selected Chiral Flavonoids: Pinocembrin and Pinostrobin [J].

Sayre, Casey L. ;

Alrushaid, Samaa ;

Martinez, Stephanie E. ;

Anderson, Hope D. ;

Davies, Neal M. .

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2015, 18 (04) :368-395

[83] QUERCETIN POTENTIATES THE EFFECT OF ADRIAMYCIN IN A MULTIDRUG-RESISTANT MCF-7 HUMAN BREAST-CANCER CELL-LINE - P-GLYCOPROTEIN AS A POSSIBLE TARGET [J].

SCAMBIA, G ;

RANELLETTI, FO ;

PANICI, PB ;

DEVINCENZO, R ;

BONANNO, G ;

FERRANDINA, G ;

PIANTELLI, M ;

BUSSA, S ;

RUMI, C ;

CIANFRIGLIA, M ;

MANCUSO, S .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (06) :459-464

[84] Population nutrikinetics of green tea extract [J].

Scholl, Catharina ;

Lepper, Anna ;

Lehr, Thorsten ;

Hanke, Nina ;

Schneider, Katharina Luise ;

Brockmoeller, Juergen ;

Seufferlein, Thomas ;

Stingl, Julia Carolin .

PLOS ONE, 2018, 13 (02)

[85] The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):: Liver regeneration and neuronal differentiation [J].

Seidah, NG ;

Benjannet, S ;

Wickham, L ;

Marcinkiewicz, J ;

Jasmin, SB ;

Stifani, S ;

Basak, A ;

Prat, A ;

Chrétien, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :928-933

[86] An Updated Review on the Multifaceted Therapeutic Potential of Calendula officinalis L. [J].

Shahane, Kiran ;

Kshirsagar, Madhuri ;

Tambe, Srushti ;

Jain, Divya ;

Rout, Srutee ;

Ferreira, Maria Karolina Martins ;

Mali, Suraj ;

Amin, Purnima ;

Srivastav, Prem Prakash ;

Cruz, Jorddy ;

Lima, Rafael Rodrigues .

PHARMACEUTICALS, 2023, 16 (04)

[87] Human MDR1 and MRP1 recognize berberine as their transport substrate [J].

Shitan, Nobukazu ;

Tanaka, Miyako ;

Terai, Koichiro ;

Ueda, Kazumitsu ;

Yazaki, Kazufumi .

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2007, 71 (01) :242-245

[88] Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study [J].

Simonen, Piia ;

Stenman, Ulf-Hakan ;

Gylling, Helena .

CLINICAL SCIENCE, 2015, 129 (05) :439-446

[89] Health benefits of resveratrol: Evidence from clinical studies [J].

Singh, Akhand Pratap ;

Singh, Rachna ;

Verma, Sumit Singh ;

Rai, Vipin ;

Kaschula, Catherine H. ;

Maiti, Pralay ;

Gupta, Subash Chandra .

MEDICINAL RESEARCH REVIEWS, 2019, 39 (05) :1851-1891

[90] Nutraceutical approaches to metabolic syndrome [J].

Sirtori, Cesare R. ;

Pavanello, Chiara ;

Calabresi, Laura ;

Ruscica, Massimiliano .

ANNALS OF MEDICINE, 2017, 49 (08) :678-697

← 2 3 4 5 6 7 8 9 10 11 →